Your session is about to expire
← Back to Search
CHK336 for Healthy Subjects
Study Summary
This trial is testing a new drug to see if it's safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Has CHK336 achieved official governmental authorization for use?
"Our team at Power has assessed CHK336 as a 1 on the safety scale due to its Phase 1 status. This indicates that there is restricted data available in regards to both efficacy and security."
What is the current enrollment size of this experiment?
"Affirmative. Clinicaltrials.gov data indicates that enrolment for this clinical trial is ongoing; it was initially posted on April 8th 2022 and the latest update came on July 18th 2022. There are 104 slots to be filled at a single medical site."
Is there still an opportunity for volunteers to join this research project?
"According to the clinicaltrials.gov listing, this medical research is currently recruiting potential participants. This trial was first published on April 8th 2022 and has seen its latest edit a mere two months ago, on July 18th of the same year."
Who is eligible to participate in this investigation?
"This medical study is seeking 104 participants between the ages of 18-45 who are in good physical health. Candidates must meet certain criteria including having a Body Mass Index (BMI) range from 19 to 32 kg/m2, agreeing to use contraception accordingly, and providing negative urine drug, tobacco, and breath alcohol tests at screening and Day-3. Furthermore all eligible individuals must be able to provide informed consent and comply with overnight stays for clinical visits during the duration of this trial."
Is the study open to geriatric patients?
"According to the enrollment criteria, candidates for this study must be between 18 and 45 years of age."
Share this study with friends
Copy Link
Messenger